Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |
mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.19 | 0.0002 |
mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.26 | 0.0004 |
mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0006 |
mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0006 |